Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00632632 : Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
PhaseN/A
AgesMin: 18 Years Max: 70 Years
Eligibility
Inclusion Criteria:

1. English-speaking adults

2. Between the ages of 18 and 70

3. Exposed to the WTC Attacks (were in towers or in the immediate area) or veterans of
the Iraq War

4. Diagnosed with PTSD symptoms.

Exclusion Criteria:

1. Presence of current organic mental disorder

2. Schizophrenia

3. Bipolar disorder

4. Depression with psychotic features

5. Current substance dependence

6. Delusional disorder

7. Active suicidal ideation, intent, or plan

8. Active homicidal ideation, intent, or plan

9. Use of pacemaker

10. Medically unstable

11. Pregnant or lactating

12. A history of severe renal disease

13. History of seizures

14. Currently taking anticoagulants, ethionamide (Trecator-SC) or isoniazid (INH)

15. History of allergic reaction to cycloserine.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00632632      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740